Connection

JOSHUA SHULMAN to Parkinson Disease

This is a "connection" page, showing publications JOSHUA SHULMAN has written about Parkinson Disease.
Connection Strength

4.122
  1. Functional screening of lysosomal storage disorder genes identifies modifiers of alpha-synuclein neurotoxicity. PLoS Genet. 2023 05; 19(5):e1010760.
    View in: PubMed
    Score: 0.554
  2. Genetics and Pathogenesis of Parkinson's Syndrome. Annu Rev Pathol. 2023 01 24; 18:95-121.
    View in: PubMed
    Score: 0.529
  3. Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity. Parkinsonism Relat Disord. 2021 03; 84:105-111.
    View in: PubMed
    Score: 0.474
  4. Reply: Lysosomal storage disorder gene variants in multiple system atrophy. Brain. 2018 07 01; 141(7):e54.
    View in: PubMed
    Score: 0.395
  5. Association of Parkinson disease risk loci with mild parkinsonian signs in older persons. JAMA Neurol. 2014 Apr; 71(4):429-35.
    View in: PubMed
    Score: 0.294
  6. Structural variation and the expanding genomic architecture of Parkinson disease. JAMA Neurol. 2013 Nov; 70(11):1355-6.
    View in: PubMed
    Score: 0.286
  7. Molecular mechanisms of cortical degeneration in Parkinson disease. Neurology. 2012 Oct 23; 79(17):1750-1.
    View in: PubMed
    Score: 0.265
  8. Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol. 2011; 6:193-222.
    View in: PubMed
    Score: 0.235
  9. Integration of transcriptome-wide association study with neuronal dysfunction assays provides functional genomics evidence for Parkinson's disease genes. Hum Mol Genet. 2023 01 27; 32(4):685-695.
    View in: PubMed
    Score: 0.136
  10. Frequency of Parkinsonism and Parkinson Disease in African Americans in the Chicago Community. J Gerontol A Biol Sci Med Sci. 2021 06 14; 76(7):1340-1345.
    View in: PubMed
    Score: 0.121
  11. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia. Brain. 2020 01 01; 143(1):234-248.
    View in: PubMed
    Score: 0.110
  12. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019 12; 18(12):1091-1102.
    View in: PubMed
    Score: 0.109
  13. Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and a-synuclein mechanisms. Mov Disord. 2019 06; 34(6):866-875.
    View in: PubMed
    Score: 0.104
  14. Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease. Brain. 2017 12 01; 140(12):3191-3203.
    View in: PubMed
    Score: 0.095
  15. Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing. Genome Biol. 2017 01 30; 18(1):22.
    View in: PubMed
    Score: 0.090
  16. Lack of evidence for a role of genetic variation in TMEM230 in the risk for Parkinson's disease in the Caucasian population. Neurobiol Aging. 2017 02; 50:167.e11-167.e13.
    View in: PubMed
    Score: 0.088
  17. A mitocentric view of Parkinson's disease. Annu Rev Neurosci. 2014; 37:137-59.
    View in: PubMed
    Score: 0.074
  18. Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol. 2012 Feb; 71(2):258-66.
    View in: PubMed
    Score: 0.063
  19. Evidence for a common pathway linking neurodegenerative diseases. Nat Genet. 2009 Dec; 41(12):1261-2.
    View in: PubMed
    Score: 0.054
  20. Emerging links between pediatric lysosomal storage diseases and adult parkinsonism. Mov Disord. 2019 05; 34(5):614-624.
    View in: PubMed
    Score: 0.026
  21. The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults. PLoS One. 2016; 11(7):e0157452.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.